Log in with your email address username.


[Comment] Interleukin-17 inhibition: a route to psoriasis clearance?

Interleukin 17 is involved in the inflammatory cascade in several immune-mediated and inflammatory diseases such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. It is, therefore, not surprising that intense development of several specific inhibitory drugs followed identification of the five members of the interleukin-17 family, among which interleukin 17A is so far the best characterised regarding its inflammatory effects.1